These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38961463)

  • 1. Genomic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) strains circulating in three university hospitals in Northern Italy over three years.
    Fox V; Mangioni D; Renica S; Comelli A; Teri A; Zatelli M; Orena BS; Scuderi C; Cavallero A; Rossi M; Casana M; Mela L; Bielli A; Scutari R; Morelli P; Cariani L; Casari E; Vismara CS; Matinato C; Callegaro A; Bottazzi B; Cassani B; Perno CF; Gori A; Muscatello A; Bandera A; Alteri C
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):70. PubMed ID: 38961463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy.
    Piazza A; Mattioni Marchetti V; Bielli A; Biffignandi GB; Piscopiello F; Giudici R; Tartaglione L; Merli M; Vismara C; Migliavacca R
    J Microbiol Immunol Infect; 2024 Jun; 57(3):457-469. PubMed ID: 38584042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic characterization of carbapenemase-producing Klebsiella pneumoniae ST307 revealed multiple introductions in Buenos Aires, Argentina.
    González-Espinosa F; Di Pilato V; Magariños F; Di Conza J; Rossolini GM; Gutkind G; Radice M; Cejas D
    J Glob Antimicrob Resist; 2024 Jun; 37():176-178. PubMed ID: 38583573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.
    Gaibani P; Re MC; Campoli C; Viale PL; Ambretti S
    Clin Microbiol Infect; 2020 Apr; 26(4):516.e1-516.e4. PubMed ID: 31740422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.
    Galani I; Antoniadou A; Karaiskos I; Kontopoulou K; Giamarellou H; Souli M
    Clin Microbiol Infect; 2019 Jun; 25(6):763.e5-763.e8. PubMed ID: 30928562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy.
    Loconsole D; Accogli M; De Robertis AL; Capozzi L; Bianco A; Morea A; Mallamaci R; Quarto M; Parisi A; Chironna M
    Ann Clin Microbiol Antimicrob; 2020 Jun; 19(1):24. PubMed ID: 32487201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V; Principe L; Andriani L; Aiezza N; Coppi M; Ricci S; Giani T; Luzzaro F; Rossolini GM
    Clin Microbiol Infect; 2023 Apr; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth characterization of multidrug-resistant NDM-1 and KPC-3 co-producing
    Posteraro B; De Maio F; Motro Y; Menchinelli G; De Lorenzis D; Marano RBM; Aljanazreh B; Errico FM; Massaria G; Spanu T; Posteraro P; Moran-Gilad J; Sanguinetti M
    Microbiol Spectr; 2024 Apr; 12(4):e0330523. PubMed ID: 38411998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime-Avibactam Resistance Associated with Increased
    Coppi M; Di Pilato V; Monaco F; Giani T; Conaldi PG; Rossolini GM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Resistance Caused by KPC-2 Encoded by Promiscuous Plasmids of the Klebsiella pneumoniae ST307 Strain.
    Lee M; Choi TJ
    Ann Lab Med; 2021 Jan; 41(1):86-94. PubMed ID: 32829583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
    Gaibani P; Bovo F; Bussini L; Lazzarotto T; Amadesi S; Bartoletti M; Viale P; Ambretti S
    J Antimicrob Chemother; 2022 May; 77(6):1570-1577. PubMed ID: 35373297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae.
    Venditti C; Butera O; Meledandri M; Balice MP; Cocciolillo GC; Fontana C; D'Arezzo S; De Giuli C; Antonini M; Capone A; Messina F; Nisii C; Di Caro A
    Clin Microbiol Infect; 2021 Jul; 27(7):1040.e1-1040.e6. PubMed ID: 33775814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
    Cejas D; Elena A; Guevara Nuñez D; Sevillano Platero P; De Paulis A; Magariños F; Alfonso C; Berger MA; Fernández-Canigia L; Gutkind G; Radice M
    J Glob Antimicrob Resist; 2019 Sep; 18():238-242. PubMed ID: 31202977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage.
    Conte V; Monaco M; Giani T; D'Ancona F; Moro ML; Arena F; D'Andrea MM; Rossolini GM; Pantosti A;
    J Antimicrob Chemother; 2016 Dec; 71(12):3386-3391. PubMed ID: 27585968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
    Bonura C; Giuffrè M; Aleo A; Fasciana T; Di Bernardo F; Stampone T; Giammanco A; ; Palma DM; Mammina C
    PLoS One; 2015; 10(7):e0132936. PubMed ID: 26177547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Analysis of
    Sugita K; Aoki K; Komori K; Nagasawa T; Ishii Y; Iwata S; Tateda K
    mSphere; 2021 Dec; 6(6):e0085021. PubMed ID: 34730375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study.
    Sotgiu G; Are BM; Pesapane L; Palmieri A; Muresu N; Cossu A; Dettori M; Azara A; Mura II; Cocuzza C; Aliberti S; Piana A
    J Hosp Infect; 2018 Aug; 99(4):413-418. PubMed ID: 29621600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omic insights into various ceftazidime-avibactam-resistant
    Bongiorno D; Bivona DA; Cicino C; Trecarichi EM; Russo A; Marascio N; Mezzatesta ML; Musso N; Privitera GF; Quirino A; Scarlata GGM; Matera G; Torti C; Stefani S
    Front Cell Infect Microbiol; 2022; 12():1010979. PubMed ID: 36683697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
    Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
    Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.